covid 19 News and Research

RSS

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

Researchers investigated the ability of kinetin (N6-furfurylaminopurine, MB-905) to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proliferation in vitro.

17 Jan 2023

The impact of cross-reactive immunity on the probability that a newly introduced SARS-CoV-2 variant will invade the host population

Researchers investigated the effect of cross-protective immunological responses on novel SARS-CoV-2 variant emergence by mathematical modeling.

17 Jan 2023

Study finds non-Omicron breakthrough infections elicit robust cross-neutralizing activity against Omicron variants across the antigenic barrier

Researchers assessed the effect of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection with a non-Omicron variant on SARS-CoV-2 BA.4/5 neutralization.

17 Jan 2023

Rural seniors benefit from pandemic-driven remote fitness boom

Eight women, all 73 or older, paced the fellowship hall at Malmo Evangelical Free Church to a rendition of Daniel O'Donnell's "Rivers of Babylon" as they warmed up for an hourlong fitness class.

17 Jan 2023

Overall patterns of SARS-CoV-2 caused by variants of concern among children and adolescents

A recent study systematically reviewed COVID-19 among adolescents and children due to SARS-CoV-2 variants of concern.

17 Jan 2023

Endothelial cell-specific protein Robo4 reduces mortality in severe infection

Pipes play an essential role in bringing water to the faucets in your home, but if one of those pipes springs a leak, damage can result.

16 Jan 2023

New test 'fishes' for multiple respiratory viruses using DNA as 'bait'

A new test that 'fishes' for multiple respiratory viruses at once using single strands of DNA as 'bait', and gives highly accurate results in under an hour, has been developed by Cambridge researchers.

16 Jan 2023

Researchers report that vectored expression of a high-affinity ACE2 microbody protein establishes a high degree of protection from SARS-CoV-2

Researchers evaluated the use of receptor decoys for SARS-CoV-2 based on soluble forms of ACE2 for immunological prophylaxis and management of COVID-19 through the use of AAV vectors.

16 Jan 2023

Intranasal mRNA-lipid nanoparticle vaccines elicit significant protection against SARS-CoV-2 in hamsters

Researchers from the United States evaluated the efficacy and immunogenicity of an intranasal messenger ribonucleic acid (mRNA)-lipid nanoparticle (LNP) vaccine against SARS-CoV-2 using a hamster model.

16 Jan 2023

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

Researchers conducted a nationwide study in Israel to determine the post-acute sequelae of SARS-CoV-2 a year after mild COVID-19.

16 Jan 2023

COVID-19 convalescent plasma transfusions significantly reduced mortality rates among hospitalized SARS-CoV-2 patients

Researchers reviewed various randomized clinical trials and cohort studies to evaluate the decrease in mortality rates among coronavirus disease 2019 (COVID-19) patients treated with COVID-19 convalescent plasma.

16 Jan 2023

What is the effectiveness of a multivalent exosome-based COVID-19 vaccine?

Researchers assessed the effectiveness of a multivalent exosome-based coronavirus disease 2019 (COVID-19) vaccine.

16 Jan 2023

What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?

Researchers assessed the efficacy of the COVID-19 second booster vaccine compared to the first booster vaccine and the protection conferred by prior COVID-19 infection.

16 Jan 2023

The trajectory of CD4+ T cell responses to mRNA vaccines in older individuals

Researchers investigated how age-related T-cell defects impacted the effectiveness of mRNA-based COVID-19 vaccines.

16 Jan 2023

Artemisia argyi plant extracts and phytochemicals shown to inhibit SARS-CoV-2 in new research

Researchers reported that Artemisia argyi extracts and phytochemicals could inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

16 Jan 2023

Study investigates the spectrum of antibody immunity across several SARS-CoV-2 variants

Researchers evaluated antibody responses to the spike proteins of the SARS-CoV-2 Wuhan-Hu-1 strain and VOCs such as the Alpha, Beta, Gamma, Delta, and Omicron.

16 Jan 2023

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

Acceptance of COVID-19 vaccines increased overall by 5.2% in 2022 compared to 2021, according to a survey of 160,000 individuals in 23 countries, published in the journal Nature Medicine.

13 Jan 2023

Scientists use paleogenomics to trace 10,000 years of human immune system evolution

Scientists from the Institut Pasteur, Université Paris Cité, the CNRS and the Collège de France have used paleogenomics to trace 10,000 years of human immune system evolution.

13 Jan 2023

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

In a recent review, the former director of the National Institute of Allergy and Infectious Diseases and former chief medical advisor to the president of the United States (U.S.), Dr. Fauci, and his team review the roadblocks to developing effective vaccines against viruses that infect the human respiratory mucosa and discuss strategies for next-generation vaccine development against mucosal respiratory viruses

13 Jan 2023

Strong bonds with close social circles and extended groups associated with better mental health, wellbeing

The time people spent with family over the festive period could have improved their health, according to new research which examined how social bonds with close social circles and extended groups relate to health and psychological wellbeing.

13 Jan 2023

covid 19 News and Research

Preclinical study shows the therapeutic value of kinetin against SARS-CoV-2

The impact of cross-reactive immunity on the probability that a newly introduced SARS-CoV-2 variant will invade the host population

Study finds non-Omicron breakthrough infections elicit robust cross-neutralizing activity against Omicron variants across the antigenic barrier

Rural seniors benefit from pandemic-driven remote fitness boom

Overall patterns of SARS-CoV-2 caused by variants of concern among children and adolescents

Endothelial cell-specific protein Robo4 reduces mortality in severe infection

New test 'fishes' for multiple respiratory viruses using DNA as 'bait'

Researchers report that vectored expression of a high-affinity ACE2 microbody protein establishes a high degree of protection from SARS-CoV-2

Intranasal mRNA-lipid nanoparticle vaccines elicit significant protection against SARS-CoV-2 in hamsters

The long-term clinical outcomes of SARS-CoV-2 infection in people with mild disease in Israel

COVID-19 convalescent plasma transfusions significantly reduced mortality rates among hospitalized SARS-CoV-2 patients

What is the effectiveness of a multivalent exosome-based COVID-19 vaccine?

What is the efficacy of the COVID-19 second booster versus the first booster with prior COVID-19 infections?

The trajectory of CD4+ T cell responses to mRNA vaccines in older individuals

Artemisia argyi plant extracts and phytochemicals shown to inhibit SARS-CoV-2 in new research

Study investigates the spectrum of antibody immunity across several SARS-CoV-2 variants

COVID-19 vaccine hesitancy still remains even though acceptance rates have increased in 2022

Scientists use paleogenomics to trace 10,000 years of human immune system evolution

What are the present challenges and future considerations in developing vaccines against mucosal respiratory viruses?

Strong bonds with close social circles and extended groups associated with better mental health, wellbeing

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News